13F-HR filed by Ishara Investments LP
Ishara Investments LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 38 holding rows worth $87,455,205.
- Accession
- 0002111609-26-000001
- Filer
- CIK 2111609
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 38 entries on the cover page, a total value of $87,455,205 stated on the cover page (in dollars after the unit check, H1), rows summing to $87,455,205 with VALUE read as dollars as filed, 13F file number 028-26490. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 40,000 | $11,789,600 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 800,000 | $6,280,000 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 100,000 | $5,943,000 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 360,000 | $5,126,400 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 160,000 | $4,273,600 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 750,000 | $3,765,000 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 400,000 | $3,584,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 36,000 | $2,753,640 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 36,000 | $2,734,560 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 5,500 | $2,679,875 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 300,000 | $2,340,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 50,000 | $2,307,000 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 70,000 | $2,156,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 100,000 | $2,101,000 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 270,000 | $2,084,400 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 24,000 | $1,965,120 | dollars as filed | |
| APOGEE ENTERPRISES INC | 037598109 | COM | 25,000 | $1,887,000 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,320,000 | $1,782,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 10,000 | $1,740,400 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 44,000 | $1,531,200 | dollars as filed | call |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 240,000 | $1,459,200 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 58,000 | $1,439,270 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 50,000 | $1,386,000 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 160,000 | $1,308,800 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 50,000 | $1,256,000 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 70,000 | $1,155,700 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 50,000 | $1,150,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 5,000 | $1,066,200 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 30,000 | $1,052,400 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 880,000 | $1,012,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 88,000 | $993,520 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 24,000 | $989,040 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 20,000 | $845,600 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 80,000 | $840,000 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 30,000 | $816,600 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 30,000 | $762,600 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 30,000 | $750,000 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 12,000 | $348,480 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002111609-26-000001 | this filing | 2026-02-17 | acceptance time not in the bulk data set |